Introduction
The U.S. IPO market is showing renewed momentum as February 2026 unfolds. Several companies have already debuted, while a wave of high-profile listings looms on the horizon. This article delivers a clear snapshot of today’s IPO landscape, spotlighting recent listings, market trends, and what investors are watching next.
Recent U.S. IPO Activity
Several companies have gone public in February, with mixed performance across sectors:
- Forgent Power Solutions, Eikon Therapeutics, and Bob’s Discount Furniture launched earlier this month. Forgent raised $1.5 billion and ended its first trading day up 7%. Eikon fell 17% on debut, while Bob’s remained nearly flat.
- According to a detailed IPO calendar, SharonAI Holdings (SHAZ) listed on February 19, raising $125 million at $30 per share and trading slightly above that level.
- Other recent listings include SOLV Energy, which raised about $589 million and is trading well above its $25 IPO price, and ARKO Petroleum, which raised roughly $183 million.
These listings reflect a cautious but active IPO environment, with performance varying significantly by sector and company.
IPO Market Outlook: A Surge Ahead
Wall Street is bracing for a major rebound in IPO activity:
- Goldman Sachs projects U.S. IPO proceeds could quadruple to a record $160 billion in 2026, with the number of deals potentially doubling to around 120.
- This surge is expected to be driven by mega-cap tech and AI firms, including potential listings from SpaceX, OpenAI, and Anthropic.
- However, analysts caution that volatility in software stocks and valuation pressures could temper issuance.
SPACs Still Leading the Charge
Special Purpose Acquisition Companies (SPACs) continue to dominate early 2026 IPO activity:
- In January, SPACs accounted for 73% of all U.S. IPOs, raising $5.6 billion. There are currently 310 active SPACs holding around $46 billion in trust, with many more deals in the pipeline.
This trend underscores the continued appeal of SPACs as a faster route to public markets amid uncertain conditions.
Global and Index Impacts
Beyond the U.S., IPO activity is also heating up globally:
- FTSE Russell has proposed a fast-entry mechanism for IPOs to ensure major new listings are incorporated into its U.S. equity indexes more swiftly.
- In India, a robust pipeline is building with over 190 companies lining up to go public in 2026, aiming to raise more than ₹2.5 lakh crore. Major names include Reliance Jio, PhonePe, Flipkart, and Zepto.
- Additionally, India faces a wave of IPO lock-in expiries between mid-February and late May, potentially unlocking $53 billion in shares and impacting market dynamics.
What Investors Are Watching Next
Looking ahead, several key developments will shape the IPO landscape:
- Medline (MDLN), the largest U.S. IPO since 2021, has surged over 60% since its December debut. Its first earnings report is due February 25, and investors are watching closely.
- The performance of upcoming mega-IPOs—especially from SpaceX, OpenAI, and Anthropic—will likely define investor sentiment and market momentum for the rest of the year.
- Market volatility, particularly in software and AI sectors, remains a key risk that could delay or downsize planned listings.
Conclusion
The IPO market in early 2026 is a mix of cautious optimism and anticipation. Recent listings like Forgent and SharonAI show varied investor response, while SPACs continue to dominate activity. Goldman Sachs’ forecast of a record-breaking $160 billion in proceeds hinges on mega-IPOs from tech giants. Meanwhile, global markets—from FTSE index rules to India’s IPO pipeline—are adapting to a fast-evolving landscape. Investors now await earnings from Medline and the potential debut of high-profile tech firms, all while watching for signs of volatility that could reshape the IPO calendar.
